Literature DB >> 15250014

Microbiological data for patients with febrile neutropenia.

Akihisa Kanamaru1, Youichi Tatsumi.   

Abstract

The pattern of bacterial infections and antimicrobial susceptibility has changed significantly during the past 20-30 years. The causative organisms for bacteremia or fungemia identified at Kinki University Hospital in 1985-1996 were compared with the isolates identified during 1997-2002. The prevalence of gram-negative organisms decreased, whereas the prevalence of gram-positive organisms increased. Staphylococcal species predominated in the second period, accounting for 22% of isolates, and methicillin-resistant Staphylococcus aureus (MRSA) increased from 5% to 14% of isolates. Pseudomonas aeruginosa ranked second, although the prevalence decreased in the second period compared with the first. Candida species were also relatively frequent (11%). Enterococcal species had an 8% prevalence. A comparison of all culture isolates showed that gram-negative isolates still predominated among the general patient population, whereas almost equal prevalence was observed in patients with hematological diseases. MRSA was the organism most frequently isolated in the general patient population, followed by P. aeruginosa. Among staphylococcal species, MRSA accounted for as much as 90% of isolates.

Entities:  

Mesh:

Year:  2004        PMID: 15250014     DOI: 10.1086/383042

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Phosphatidylinositol-(3,4,5)-Trisphosphate Induces Phagocytosis of Nonmotile Pseudomonas aeruginosa.

Authors:  Sally Demirdjian; Daniel Hopkins; Hector Sanchez; Michael Libre; Scott A Gerber; Brent Berwin
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

2.  68-year-old man with neutropenic fever and upper extremity hematoma.

Authors:  Elena Beam; Aaron S Mansfield; Carrie A Thompson
Journal:  Mayo Clin Proc       Date:  2012-12       Impact factor: 7.616

Review 3.  Oncologic Emergencies-The Old, the New, and the Deadly.

Authors:  Krishna Thandra; Zuhair Salah; Sanjay Chawla
Journal:  J Intensive Care Med       Date:  2018-11-09       Impact factor: 3.510

4.  Current spectrum of bacterial infections in patients with nosocomial fever and neutropenia.

Authors:  Davood Yadegarynia; Alireza Fatemi; Masih Mahdizadeh; Reihaneh Kabiri Movahhed; Mohammad Afshin Alizadeh
Journal:  Caspian J Intern Med       Date:  2013

5.  Enhancement of neutrophil function by interleukin-18 therapy protects burn-injured mice from methicillin-resistant Staphylococcus aureus.

Authors:  Manabu Kinoshita; Hiromi Miyazaki; Satoshi Ono; Akihito Inatsu; Hiroyuki Nakashima; Hironori Tsujimoto; Nariyoshi Shinomiya; Daizoh Saitoh; Shuhji Seki
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

6.  Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.

Authors:  Habip Gedik; Funda Şimşek; Taner Yıldırmak; Arzu Kantürk; Demet Aydın; Naciye Demirel; Osman Yokuş; Deniz Arıca
Journal:  Indian J Hematol Blood Transfus       Date:  2014-05-14       Impact factor: 0.900

Review 7.  Rapid Fire: Infectious Disease Emergencies in Patients with Cancer.

Authors:  Stephanie Charshafian; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2018-06-11       Impact factor: 2.264

Review 8.  Treatment of invasive candidiasis in immunocompromised pediatric patients.

Authors:  Brian T Fisher; Theoklis E Zaoutis
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

9.  Local audit of empiric antibiotic therapy in bacteremia: A retrospective cohort study.

Authors:  Anthony D Bai; Neal Irfan; Cheryl Main; Philippe El-Helou; Dominik Mertz
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

Review 10.  Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

Authors:  Dong-Gun Lee; Sung-Han Kim; Soo Young Kim; Chung-Jong Kim; Wan Beom Park; Young Goo Song; Jung-Hyun Choi
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.